Received Mar 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | 3004007 | PO / MO |
The patient ate five minutes after took Vivotif; Case reference number US-BN-2024-001774 is a spontaneous case report initially received from a pharmacist via Med Communications (reference number USBAV24-0686) on 08-Apr-2024 and concerns a 53-years-old male patient. The patient's medical history and concomitant medication details were not provided. On 07-Apr-2024, as reported the patient ate and after five minutes took first dose of Vivotif (batch number: 3004007), at unknown dose, orally, site administration was unknown, for indication reported as immunization against disease caused by salmonella typhi (explicitly coded as 'Product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A 53-year-old male patient ate and after five minutes took the first dose of Vivotif for indication reported as immunization against disease caused by salmonella typhi, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A 53-year-old male patient ate and after five minutes took the first dose of Vivotif for indication reported as immunization against disease caused by salmonella typhi, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to Vivotif vaccine. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error has been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None